Patient
P2B-136
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Epworth HealthCare Clinical Trials and Research Centre (Richmond, Australia) (Dr. Dubois)
consented 2013-07-17
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 3
Grade 1 constipation with onset in cycle 6 (2013-11-13); assessed as not related to study drug (not related); resolved 2013-11-15.
Grade 2 nausea with onset in cycle 4 (2013-10-01); assessed as not related to study drug (unlikely); resolved 2013-10-02.
Grade 1 stomatitis with onset in cycle 1 (2013-08-02); assessed as related to study drug (probable); resolved 2013-08-09.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.